Fatigue in newly diagnosed acute myeloid leukaemia: general population comparison and predictive factors Redazione 6 Maggio 2021 ...
The current role of interferon in hairy cell leukaemia: clinical and molecular aspects Redazione 6 Maggio 2021 ...
he detection of circulating plasma cells may improve tThe Revised International Staging System (R‐ISS) risk stratification of patients with newly diagnosed multiple myeloma Redazione 6 Maggio 2021 ...
MRD-Based Therapeutic Decisions in Genetically Defined Subsets of Adolescents and Young Adult Philadelphia-Negative ALL Redazione 6 Maggio 2021 ...
Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trial Redazione 6 Maggio 2021 ...
Next‐generation sequencing improves BCR‐ABL1 mutation detection in Philadelphia chromosome‐positive acute lymphoblastic leukaemia Redazione 22 Aprile 2021 ...
A brief rituximab, bendamustine, mitoxantrone (R‐BM) induction followed by rituximab consolidation in elderly patients with advanced follicular lymphoma: a phase II study by the Fondazione Italiana Linfomi (FIL) Redazione 22 Aprile 2021 ...
Safety and Effectiveness of Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma: The MANHATTAN Nonrandomized Clinical Trial Redazione 22 Aprile 2021 ...